In this study, we investigated the potential antitumor effect of solamargine on cervical cancer and revealed a finding that solamargine could suppress the growth and metastasis of cervical cancer cells mediated by the CXCL3-regulated Erk signaling pathway, which provided a potential therapeutic strategy for cervical cancer. This evidence concerns the gene MAPK1 and cervical carcinoma.